Title

慢性B或C型肝炎病患之疾病相關烙印與自我照顧效能之相關性探討

Translated Titles

Chronic Hepatitis-related Stigma and Self-care Efficacy in Patients with Chronic Hepatitis B or C Infection

DOI

10.6342/NTU201603556

Authors

許馥郁

Key Words

慢性肝炎 ; 烙印 ; 自我照顧 ; 自我效能 ; 人格特質 ; 症狀 ; Chronic hepatitis, Stigma ; Self-care ; Self-efficacy ; Personality ; Symptom

PublicationName

臺灣大學護理學研究所學位論文

Volume or Term/Year and Month of Publication

2016年

Academic Degree Category

碩士

Advisor

孫秀卿

Content Language

繁體中文

Chinese Abstract

慢性B及C型肝炎是台灣高盛行率的肝臟疾病,並且是肝硬化、肝癌、肝衰竭的高危險群。雖然近年慢性B及C型肝炎的治療有很大的進步,但是仍有許多病患未接受治療,加上治療效果不易預期,多數病患仍需長期與肝炎病毒共處,因此,病患的自我照顧(self-care)角色日顯重要,其強調以個人為中心,使病患能夠自我掌控疾病,避免疾病進展及維護生活品質,而自我效能(self-efficacy)已被證實是影響自我照顧行為的重要因素。此外,病患除了需要面對疾病帶來身體的改變,還需因應疾病的傳染性和對生命的威脅而造成的烙印(stigma)感受,然而國內尚未有烙印及自我照顧效能的相關研究。因此,本研究探討慢性肝炎病患的烙印與自我照顧效能現況,並探討影響烙印及自我照顧效能的相關因素,研究目的為:(1) 瞭解慢性肝炎病患疾病相關烙印之現況;(2) 瞭解慢性肝炎病患人口學特質及疾病特性、疾病症狀、人格特質與慢性肝炎相關烙印的相關性;(3) 瞭解慢性肝炎病患自我照顧效能之現況;(4) 瞭解慢性肝炎病患人口學特質及疾病特性、疾病症狀、人格特質、慢性肝炎相關烙印與自我照顧效能的相關性,並探討自我照顧效能的顯著相關因素。 本研究為橫斷式相關性研究,採立意取樣及結構性問卷方式於台北某兩家醫學中心肝膽腸胃科門診、雲林某一區域醫院肝膽腸胃科門診、彰化某兩家鄉鎮衛生所及肝病防治基金會104年7月於桃園舉辦的篩檢活動進行收案,收案對象為慢性B或C型肝炎、無肝癌或肝硬化、目前未進行標準抗病毒治療之病患,研究工具包含個人基本屬性問卷、肝臟疾病症狀量表、慢性肝炎病毒感染者烙印量表、台灣版D型人格量表、慢性肝炎自我照顧效能量表進行資料收集。研究資料以描述性統計,包括平均值、標準差、百分比、排序等方式描述各變項的分佈狀況、平均得分;以推論性統計,包括單變數及多元邏輯斯迴歸分析研究變項的相關性,共收案207位,平均年齡為56.4歲。研究結果顯示:(1) 慢性肝炎病患的烙印感受程度偏低,然而在保密病情及負向自我評價面向的烙印程度較高;(2) 慢性肝炎相關烙印與輸血感染、疾病症狀(症狀嚴重度及症狀困擾)、D型人格(負向情緒及社交壓抑)有顯著正相關;(3) 慢性肝炎病患的自我照顧效能普遍良好,然而在日常保健(包括症狀監控、規律運動、良好生活作息及均衡飲食)的面向較差;(4) 自我照顧效能與婚姻、抽菸史有顯著相關,與疾病症狀(症狀嚴重度及症狀困擾)、慢性肝炎相關烙印有顯著負相關;在調整相關因素後,以多元邏輯斯迴歸分析發現婚姻、抽煙史、症狀嚴重度及慢性肝炎相關烙印是自我照顧效能的顯著解釋因素。 藉由研究結果建議如下:(1) 慢性肝炎病患的烙印感受多源於害怕公開病情及負向自我評價,臨床醫護人員在照護慢性肝炎病患時,可給予衛教及心理諮商,提升慢性肝炎病患的正向經驗及建立疾病的正面形象,傾聽並協助改善病患的症狀困擾,並進一步篩檢有D型人格特質的病患,加強其衛教及心理支持,以減少烙印對病患生心理的影響;(2) 慢性肝炎病患普遍缺乏對日常保健的信心,針對日常保健對健康的益處需加強宣導;(3)臨床照護上除了鼓勵病患接受治療以改善疾病症狀,減少病患的烙印感受有助於增加自我照顧效能、促進病患自我照顧能力;(4) 雖然D型人格在本研究中無法顯著解釋自我照顧效能,但有將近30%的慢性肝炎病患擁有此人格特質,並且與烙印、自我照顧效能等心理健康有顯著相關,D型人格已知與健康行為及特定疾病預後有關,在慢性肝炎病患的影響則值得更多研究。研究結果可幫助未來降低慢性肝炎相關烙印、提升病患自我照顧效能的相關臨床照護、護理教育及護理研究。 關鍵字:慢性肝炎、烙印、自我照顧、自我效能、人格特質、症狀

English Abstract

Chronic hepatitis B and C are common in Taiwan and also the leading cause of liver cirrhosis, hepatocellular carcinoma and liver failure. Although effective therapies have recently emerged for the disease, not all patients receive treatment and the outcome is not always successful. As the majority of patients have to live with a long-term condition, the role of self-care which focuses on indivisual-centered is increasingly critical for them to manage disease, prevent disease progression and have better quality of life. Self-efficacy is believed to have a great impact on self-care behavior. In addition to manage physical change of chronic illness, patients living with hepatitis also cope with perception of stigma due to infectious and fatal of the disease. However, no study regarding hepatitis-related stigma or self-care efficacy has been carried out in Taiwan. The current study attempted to explore the current status of hepatitis-related stigma and self-care efficacy and their association factors in a group of chronic hepatitis B or C. The purposes of this study were to: (1)explore the status of hepatitis-related stigma among chronic hepatitis patients; (2) explore the relationships among demographic and disease-related, liver disease symptoms, personality factors and hepatitis-related stigma; (3) explore the status of self-care efficacy among chronic hepatitis patients; and(4) understand the demographic and disease-related, liver disease symptoms, personality and hepatitis-related stigma factors associated with self-care efficacy and explore significant explanatory factors. We conducted a cross-sectional, structured questionnaire survey with purposive sampling to recruit eligible participants from outpatient settings in six sites, including three gastroenterology departments of two medical centers and a free hepatitis screening activity held in July 2015 in northern Taiwan, one metropolitan hospital and two public health centers in southern Taiwan. The inclusion criteria were chronic hepatitis B or C patients and who still receiving standard antiviral therapy or suffering from liver cirrhosis or liver cancer were excluded. Research materials included demographic and disease-related information, liver disease symptoms and distress assessed with the Liver Disease Symptom Index 2.0, personality assessed by the Type D scale-14 Taiwanese version-revised, hepatitis-related stigma assessed with the Stigma Scale of Chronic Hepatitis Patients, self-care efficacy measured with the Self-care Efficacy Scale of chronic hepatitis patients. Data were analyzed by descriptive statistics and logistic regression methods. A total of 207 patients in this study and average age was 56.4. The results indicated that: (1) The overall mean scores of hepatitis-related stigma favored a lower perception, however, the degree of nondisclosure and negative self-estimation were relative high; (2) The factors of transfusion etiology, liver disease symptoms (include symptom severity and symptom distress) and type D personality (include negative affection and social inhibition) were associated with stigma degree; (3) The overall mean score of self-care efficacy was around the high-level, but the degree of health-care efficacy (include exercise, diet, regular lifestyle and self-monitor symptoms) was relative low; (4) The factors of marital status, smoking history,liver disease symptoms (include symptom severity and symptom distress), type D personality (include negative affection and social inhibition) and hepatitis-related stigma were associated with self-care efficacy degree. After adjusted association factors with multiple logistic regression, marital status, smoking history, symptom severity and hepatitis-related stigma were significant determinants of self-care efficacy. In conclusion and suggestion: (1) the perception of hepatitis-related stigma centralize on the level of nondisclosure and negative self-estimation. The care for chronic hepatitis could focus on promotion of positive experience and image of disease, listening and assist patients to cope with symptom distresses with education and psychological consultation. And screening of type D personality among patients to reinforce education and give mental support for them could help to reduce negative impact of physical and mental health by stigma; (2) The level of confidence with health-care needs to be enhanced by reinforcing its benefits; (3) In addition to improve disease symptoms by encouraging patients to accept treatment, help patients to reduce perception of hepatitis-related stigma are beneficial to enhance self-care efficacy and self-care ability. (4) Although type D personality not significantly explained the study outcome variables after adjusting other factors, nearly 30 percent of patients had this personality and associated with psychological variables such as stigma and self-care efficacy in the current study. As type D personality is suggested to impair health behavior and health outcomes with specific disease, more studies need to be carried out in this particular group. This study provides valuable information about hepatitis-related stigma and self-care efficacy and it is helpful in clinical care, education and future research in nursing. Key words:Chronic hepatitis, Stigma, Self-care, Self-efficacy, Personality, Symptom.

Topic Category 醫藥衛生 > 社會醫學
醫學院 > 護理學研究所
Reference
  1. Aljasem, L. I., Peyrot, M., Wissow, L., & Rubin, R. R. (2001). The impact of barriers and self-efficacy on self-care behaviors in type 2 diabetes. The Diabetes Educator, 27(3), 393-404.
    連結:
  2. Amy Janke, E., McGraw, S., Garcia-Tsao, G., & Fraenkel, L. (2008). Psychosocial Issues in Hepatitis C: A Qualitative Analysis. Psychosomatics, 49(6), 494-501. doi: http://dx.doi.org/10.1176/appi.psy.49.6.494
    連結:
  3. Balfour, L., Cooper, C., Kowal, J., Tasca, G. A., Silverman, A., Kane, M., & Garber, G. (2006). Depression and cigarette smoking independently relate to reduced health-related quality of life among Canadians living with hepatitis C. Canadian Journal of Gastroenterology, 20(2), 81.
    連結:
  4. Bandura, A. (1977). Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev, 84(2), 191-215.
    連結:
  5. Barkhuizen, A., Rosen, H. R., Wolf, S., Flora, K., Benner, K., & Bennett, R. M. (1999). Musculoskeletal pain and fatigue are associated with chronic hepatitis C. The American journal of gastroenterology, 94(5), 1355-1360.
    連結:
  6. Bartels, H., Pedersen, S. S., van der Laan, B. F., Staal, M. J., Albers, F. W., & Middel, B. (2010). The impact of Type D personality on health-related quality of life in tinnitus patients is mainly mediated by anxiety and depression. Otology & Neurotology, 31(1), 11-18.
    連結:
  7. Bohanny, W., Wu, S. F., Liu, C. Y., Yeh, S. H., Tsay, S. L., & Wang, T. J. (2013). Health literacy, self-efficacy, and self-care behaviors in patients with type 2 diabetes mellitus. J Am Assoc Nurse Pract, 25(9), 495-502. doi: 10.1111/1745-7599.12017
    連結:
  8. Bonner, J. E., Esserman, D. A., Golin, C. E., & Evon, D. M. (2013). Self-Efficacy and Adherence to Antiviral Treatment for Chronic Hepatitis C. J Clin Gastroenterol. doi: 10.1097/mcg.0000000000000055
    連結:
  9. Butt, G., Paterson, B. L., & McGuinness, L. K. (2007). Living With the Stigma of Hepatitis C. Western Journal of Nursing Research, 30(2), 204-221. doi: 10.1177/0193945907302771
    連結:
  10. Cacoub, P., Renou, C., Rosenthal, E., Cohen, P., Loury, I., Loustaud-Ratti, V., . . . Musset, L. (2000). Extrahepatic manifestations associated with hepatitis C virus infection: a prospective multicenter study of 321 patients. Medicine, 79(1), 47-56.
    連結:
  11. Che, Y., You, J., Chongsuvivatwong, V., Li, L., Sriplung, H., Yan, Y., . . . Chen, H. (2014). Dynamics and liver disease specific aspects of quality of life among patients with chronic liver disease in yunnan, china. Asian Pacific journal of cancer prevention: APJCP, 15(12), 4765.
    連結:
  12. Chen, C. H., Yang, P. M., Huang, G. T., Lee, H. S., Sung, J. L., & Sheu, J. C. (2007). Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc, 106(2), 148-155. doi: 10.1016/s0929-6646(09)60231-x
    連結:
  13. Chen, C. J., Yu, M. W., & Liaw, Y. F. (1997). Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol, 12(9-10), S294-308.
    連結:
  14. Chen, Y.-W., Liu, C.-C., & Perng, D.-S. (2013). Perceptions about preventing hepatocellular carcinoma among patients with chronic hepatitis in Taiwan. World Journal of Gastroenterology : WJG, 19(22), 3459-3465. doi: 10.3748/wjg.v19.i22.3459
    連結:
  15. Chu, F. Y., Chiang, S. C., Su, F. H., Chang, Y. Y., & Cheng, S. H. (2009). Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan. J Med Virol, 81(6), 973-978. doi: 10.1002/jmv.21481
    連結:
  16. Chuang, S.-C., Lee, Y.-C. A., Hashibe, M., Dai, M., Zheng, T., & Boffetta, P. (2010). Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiology Biomarkers & Prevention, 19(5), 1261-1268.
    連結:
  17. Conrad, S., Garrett, L. E., Cooksley, W. G. E., Dunne, M. P., & MacDonald, G. A. (2006). Living with chronic hepatitis C meansyou just haven't got a normal life any more'. Chronic Illness, 2(2), 121-131.
    連結:
  18. Corrigan, P. W., Larson, J. E., & Rüsch, N. (2009). Self-stigma and the "why try" effect: Impact on life goals and evidence-based practices. World Psychiatry, 8(2), 75-81.
    連結:
  19. Cotler, S. J., Cotler, S., Xie, H., Luc, B. J., Layden, T. J., & Wong, S. S. (2012). Characterizing hepatitis B stigma in Chinese immigrants. Journal of Viral Hepatitis, 19(2), 147-152. doi: 10.1111/j.1365-2893.2011.01462.x
    連結:
  20. Crockett, B., & Gifford, S. M. (2004). “Eyes Wide Shut”: narratives of women living with hepatitis C in Australia. Women & health, 39(4), 117-137.
    連結:
  21. Cross, M. J., March, L. M., Lapsley, H. M., Byrne, E., & Brooks, P. M. (2006). Patient self-efficacy and health locus of control: Relationships with health status and arthritis-related expenditure. Rheumatology, 45(1), 92-96.
    連結:
  22. Day, C., Jayasuriya, R., & Stone, G. (2004). Hepatitis C-related discrimination in New South Wales. Australian Health Review, 27(2), 57-60.
    連結:
  23. De Fruyt, F., & Denollet, J. (2002). Type D personality: A five-factor model perspective. Psychology and Health, 17(5), 671-683.
    連結:
  24. Denollet, J. (1991). Negative affectivity and repressive coping: pervasive influence on self-reported mood, health, and coronary-prone behavior. Psychosom Med, 53(5), 538-556.
    連結:
  25. Denollet, J. (2000). Type D personality. A potential risk factor refined. J Psychosom Res, 49(4), 255-266.
    連結:
  26. Denollet, J. (2005). DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med, 67(1), 89-97. doi: 10.1097/01.psy.0000149256.81953.49
    連結:
  27. Denollet, J., Sys, S. U., & Brutsaert, D. L. (1995). Personality and mortality after myocardial infarction. Psychosom Med, 57(6), 582-591.
    連結:
  28. Denollet, J., Sys, S. U., Stroobant, N., Rombouts, H., Gillebert, T. C., & Brutsaert, D. L. (1996). Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet, 347(8999), 417-421.
    連結:
  29. Denollet, J., Vaes, J., & Brutsaert, D. L. (2000a). Inadequate response to treatment in coronary heart disease : adverse effects of type D personality and younger age on 5-year prognosis and quality of life. Circulation, 102(6), 630-635.
    連結:
  30. Denollet, J., Vaes, J., & Brutsaert, D. L. (2000b). Inadequate response to treatment in coronary heart disease: Adverse effects of type D personality and younger age on 5-year prognosis and quality of life. Circulation, 102(6), 630-635.
    連結:
  31. Dieperink, E., Willenbring, M., & Ho, S. B. (2000). Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review. Am J Psychiatry, 157(6), 867-876. doi: 10.1176/appi.ajp.157.6.867
    連結:
  32. DiIorio, C., Osborne Shafer, P., Letz, R., Henry, T., Schomer, D. L., & Yeager, K. (2003). The association of stigma with self-management and perceptions of health care among adults with epilepsy. Epilepsy Behav, 4(3), 259-267.
    連結:
  33. Dilorio, C., Faherty, B., & Manteuffel, B. (1992). The development and testing of an instrument to measure self-efficacy in individuals with epilepsy. Journal of Neuroscience Nursing, 24(1), 9-13.
    連結:
  34. Drazic, Y. N., & Caltabiano, M. L. (2013). Chronic hepatitis B and C: Exploring perceived stigma, disease information, and health-related quality of life. Nursing & Health Sciences, 15(2), 172-178. doi: 10.1111/nhs.12009
    連結:
  35. Dubayova, T., Nagyova, I., Havlikova, E., Rosenberger, J., Gdovinova, Z., Middel, B., . . . Groothoff, J. W. (2009). The association of type D personality with quality of life in patients with Parkinson's disease. Aging Ment Health, 13(6), 905-912. doi: 10.1080/13607860903046529
    連結:
  36. Dwight, M. M., Kowdley, K. V., Russo, J. E., Ciechanowski, P. S., Larson, A. M., & Katon, W. J. (2000). Depression, fatigue, and functional disability in patients with chronic hepatitis C. Journal of psychosomatic research, 49(5), 311-317.
    連結:
  37. Earnshaw, V. A., & Quinn, D. M. (2012). The impact of stigma in healthcare on people living with chronic illnesses. Journal of Health Psychology, 17(2), 157-168.
    連結:
  38. El-Zayadi, A., Selim, O., Hamdy, H., El-Tawil, A., Badran, H. M., Attia, M., & Saeed, A. (2004). Impact of cigarette smoking on response to interferon therapy in chronic hepatitis C Egyptian patients. World Journal of Gastroenterology, 10(20), 2963-2966.
    連結:
  39. Evon, D. M., Golin, C. E., Fried, M. W., & Keefe, F. J. (2013). Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute? J Consult Clin Psychol, 81(2), 361-374. doi: 10.1037/a0029030
    連結:
  40. Fife, B. L., & Wright, E. R. (2000). The dimensionality of stigma: a comparison of its impact on the self of persons with HIV/AIDS and cancer. J Health Soc Behav, 41(1), 50-67.
    連結:
  41. Fontana, R. J., Hussain, K. B., Schwartz, S. M., Moyer, C. A., Su, G. L., & Lok, A. S. (2002). Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. Journal of Hepatology, 36(3), 401-407.
    連結:
  42. Franks, P., Chapman, B., Duberstein, P., & Jerant, A. (2009). Five factor model personality factors moderated the effects of an intervention to enhance chronic disease management self-efficacy. British Journal of Health Psychology, 14(3), 473-487. doi: 10.1348/135910708X360700
    連結:
  43. Freidl, M., Lang, T., & Scherer, M. (2003). How psychiatric patients perceive the public's stereotype of mental illness. Soc Psychiatry Psychiatr Epidemiol, 38(5), 269-275.
    連結:
  44. Fry, M., & Bates, G. (2012). The tasks of self-managing hepatitis C: The significance of disclosure. Psychology & Health, 27(4), 460-474. doi: 10.1080/08870446.2011.592982
    連結:
  45. Gane, E., Unit, N. L. T., Hamid, S., Jafri, W., Leung, N., & Piratvisuth, C. T. (2007). Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. Journal of Gastroenterology and Hepatology, 22, 615-633.
    連結:
  46. Gapinski, M. A., & Zucker, D. M. (2005). Factors influencing the development of a hepatitis C exercise protocol: a literature review. Gastroenterology Nursing, 28, S10-S18.
    連結:
  47. Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009). Diagnosis, management, and treatment of hepatitis C: an update. Hepatology, 49(4), 1335-1374.
    連結:
  48. Gilmour, J., & Williams, L. (2011). Type D personality is associated with maladaptive health-related behaviours. Journal of Health Psychology, 1359105311423117.
    連結:
  49. Gist, M. E., & Mitchell, T. R. (1992). Self-efficacy: A theoretical analysis of its determinants and malleability. Academy of Management review, 17(2), 183-211.
    連結:
  50. Glacken, M., Kernohan, G., & Coates, V. (2001). Diagnosed with Hepatitis C: a descriptive exploratory study. Int J Nurs Stud, 38(1), 107-116.
    連結:
  51. Goffman, E. (2009). Stigma: Notes on the management of spoiled identity: Simon and Schuster.
    連結:
  52. Golden, J., Conroy, R. M., O'Dwyer, A. M., Golden, D., & Hardouin, J. B. (2006). Illness-related stigma, mood and adjustment to illness in persons with hepatitis C. Soc Sci Med, 63(12), 3188-3198. doi: 10.1016/j.socscimed.2006.08.005
    連結:
  53. Groessl, E. J., Weingart, K. R., Stepnowsky, C. J., Gifford, A. L., Asch, S. M., & Ho, S. B. (2011). The hepatitis C self-management programme: a randomized controlled trial. Journal of Viral Hepatitis, 18(5), 358-368. doi: 10.1111/j.1365-2893.2010.01328.x
    連結:
  54. Grogan, A., & Timmins, F. (2010). Patients' perceptions of information and support received from the nurse specialist during HCV treatment. J Clin Nurs, 19(19-20), 2869-2878. doi: 10.1111/j.1365-2702.2010.03239.x
    連結:
  55. Gutteling, J., De Man, R., Busschbach, J., & Darlington, A. (2007). Overview of research on health-related quality of life in patients with chronic liver disease. Neth J Med, 65(7), 227-234.
    連結:
  56. Gutteling, J., De Man, R., Van Der Plas, S., Schalm, S., Busschbach, J., & DARLINGTON, A. S. (2006). Determinants of quality of life in chronic liver patients. Alimentary Pharmacology & Therapeutics, 23(11), 1629-1635.
    連結:
  57. Harris, D. R., Gonin, R., Alter, H. J., Wright, E. C., Buskell, Z. J., Hollinger, F. B., & Seeff, L. B. (2001). The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Annals of internal medicine, 134(2), 120-124.
    連結:
  58. Heeren, M., Sojref, F., Schuppner, R., Worthmann, H., Pflugrad, H., Tryc, A. B., . . . Weissenborn, K. (2014). Active at night, sleepy all day--sleep disturbances in patients with hepatitis C virus infection. J Hepatol, 60(4), 732-740. doi: 10.1016/j.jhep.2013.11.030
    連結:
  59. Hezode, C., Lonjon, I., Roudot-Thoraval, F., Mavier, J., Pawlotsky, J., Zafrani, E., & Dhumeaux, D. (2003). Impact of smoking on histological liver lesions in chronic hepatitis C. Gut, 52(1), 126-129.
    連結:
  60. Hickman, I., Clouston, A., Macdonald, G., Purdie, D., Prins, J., Ash, S., . . . Powell, E. (2002). Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut, 51(1), 89-94.
    連結:
  61. Hilsabeck, R. C., Hassanein, T. I., Carlson, M. D., Ziegler, E. A., & Perry, W. (2003). Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc, 9(6), 847-854. doi: 10.1017/s1355617703960048
    連結:
  62. Holden, G. (1992). The relationship of self-efficacy appraisals to subsequent health related outcomes: A meta-analysis. Social work in health care, 16(1), 53-93.
    連結:
  63. Hoofnagle, J. H. (1997). Hepatitis C: the clinical spectrum of disease. Hepatology, 26(S3), 15S-20S.
    連結:
  64. Hwang, S. J., Luo, J. C., Chu, C. W., Lai, C. R., Lu, C. L., Tsay, S. H., . . . Lee, S. D. (2001). Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation. Journal of Gastroenterology and Hepatology, 16(2), 190-195.
    連結:
  65. Inzlicht, M., McKay, L., & Aronson, J. (2006). Stigma as ego depletion how being the target of prejudice affects self-control. Psychological Science, 17(3), 262-269.
    連結:
  66. Kamitani, E., Fukuoka, Y., & Dawson-Rose, C. (2015). Knowledge, Self-efficacy, and Self-perceived Risk for Cardiovascular Disease among Asians Living With HIV: The Influence of HIV Stigma and Acculturation. Journal of the Association of Nurses in AIDS Care, 26(4), 443-453. doi: http://dx.doi.org/10.1016/j.jana.2014.12.006
    連結:
  67. Kang, S. Y., Deren, S., Andia, J., Colon, H. M., & Robles, R. (2004). Effects of changes in perceived self-efficacy on HIV risk behaviors over time. Addict Behav, 29(3), 567-574. doi: 10.1016/j.addbeh.2003.08.026
    連結:
  68. Kleinman, L., Mannix, S., Yuan, Y., Kummer, S., L'Italien, G., & Revicki, D. (2012). Review of patient-reported outcome measures in chronic hepatitis C. Health Qual Life Outcomes, 10, 92. doi: 10.1186/1477-7525-10-92
    連結:
  69. Koller, M., Kussman, J., Lorenz, W., Jenkins, M., Voss, M., Arens, E., . . . Rothmund, M. (1996). Symptom reporting in cancer patients: The role of negative affect and experienced social stigma. Cancer, 77(5), 983-995. doi: 10.1002/(SICI)1097-0142(19960301)77:5<983::AID-CNCR27>3.0.CO;2-Z
    連結:
  70. Lang, C. A., Conrad, S., Garrett, L., Battistutta, D., Cooksley, W. G., Dunne, M. P., & Macdonald, G. A. (2006). Symptom prevalence and clustering of symptoms in people living with chronic hepatitis C infection. J Pain Symptom Manage, 31(4), 335-344. doi: 10.1016/j.jpainsymman.2005.08.016
    連結:
  71. Latka, M. H., Hagan, H., Kapadia, F., Golub, E. T., Bonner, S., Campbell, J. V., . . . Strathdee, S. A. (2008). A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. Am J Public Health, 98(5), 853-861. doi: 10.2105/ajph.2007.113415
    連結:
  72. Lavanchy, D. (2004). Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of Viral Hepatitis, 11(2), 97-107.
    連結:
  73. Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal, and coping. New York: Springer Pub. Co.
    連結:
  74. Lee, H., Fawcett, J., Yang, J. H., & Hann, H.-W. (2012). Correlates of Hepatitis B Virus Health-Related Behaviors of Korean Americans: A Situation-Specific Nursing Theory. Journal of Nursing Scholarship, 44(4), 315-322. doi: 10.1111/j.1547-5069.2012.01468.x
    連結:
  75. Lee, T. S., Chen, Y. P., & Chang, C. W. (2011). Gender differences in the perceived self-efficacy of safer HIV practices among polydrug abusers in Taiwan. Compr Psychiatry, 52(6), 763-768. doi: 10.1016/j.comppsych.2010.10.015
    連結:
  76. Li, X., Huang, L., Wang, H., Fennie, K. P., He, G., & Williams, A. B. (2011). Stigma mediates the relationship between self-efficacy, medication adherence, and quality of life among people living with HIV/AIDS in China. AIDS Patient Care STDS, 25(11), 665-671. doi: 10.1089/apc.2011.0174
    連結:
  77. Liao, K. F., Lai, S. W., Chang, W. L., & Hsu, N. Y. (2006). Screening for viral hepatitis among male non-drug-abuse prisoners. Scand J Gastroenterol, 41(8), 969-973. doi: 10.1080/00365520500535576
    連結:
  78. Liaw, Y. F., Kao, J. H., Piratvisuth, T., Chan, H. L., Chien, R. N., Liu, C. J., . . . Omata, M. (2012). Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int, 6(3), 531-561. doi: 10.1007/s12072-012-9365-4
    連結:
  79. Liu, H., Xu, Y., Sun, Y., & Dumenci, L. (2014). Measuring HIV stigma at the family level: psychometric assessment of the Chinese Courtesy Stigma Scales (CCSSs). PLoS One, 9(3), e92855. doi: 10.1371/journal.pone.0092855
    連結:
  80. Loguercio, C., Federico, A., Masarone, M., Torella, R., Blanco, C. D. V., & Persico, M. (2008). The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis. The American journal of gastroenterology, 103(12), 3159-3166.
    連結:
  81. Lorig, K. R., Sobel, D. S., Stewart, A. L., Brown Jr, B. W., Bandura, A., Ritter, P., . . . Holman, H. R. (1999). Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization a randomized trial. Medical Care, 37(1), 5-14.
    連結:
  82. Marks, R., & Allegrante, J. P. (2005). A review and synthesis of research evidence for self-efficacy-enhancing interventions for reducing chronic disability: implications for health education practice (part II). Health promotion practice, 6(2), 148-156.
    連結:
  83. McBride, S. H. (1991). Comparative analysis of three instruments designed to measure self-care agency. Nurs Res, 40(1), 12-16.
    連結:
  84. McDonald, J., Jayasuriya, J., Bindley, P., Gonsalvez, C., & Gluseska, S. (2002). Fatigue and psychological disorders in chronic hepatitis C. J Gastroenterol Hepatol, 17(2), 171-176.
    連結:
  85. Miller, E. R., McNally, S., Wallace, J., & Schlichthorst, M. (2012). The ongoing impacts of hepatitis c--a systematic narrative review of the literature. BMC Public Health, 12, 672. doi: 10.1186/1471-2458-12-672
    連結:
  86. Miller, E. R., McNally, S., Wallace, J., & Schlichthorst, M. (2012). The ongoing impacts of hepatitis c - a systematic narrative review of the literature. BMC Public Health, 12, 672-672. doi: 10.1186/1471-2458-12-672
    連結:
  87. Molloy, G. J., Randall, G., Wikman, A., Perkins-Porras, L., Messerli-Bürgy, N., & Steptoe, A. (2012). Type D personality, self-efficacy, and medication adherence following an acute coronary syndrome. Psychosom Med, 74(1), 100-106.
    連結:
  88. Mols, F., & Denollet, J. (2010). Type D personality in the general population: a systematic review of health status, mechanisms of disease, and work-related problems. Health Qual Life Outcomes, 8, 9. doi: 10.1186/1477-7525-8-9
    連結:
  89. Mommersteeg, P. M., Kupper, N., & Denollet, J. (2010). Type D personality is associated with increased metabolic syndrome prevalence and an unhealthy lifestyle in a cross-sectional Dutch community sample. BMC Public Health, 10(1), 714.
    連結:
  90. Moore, G. A., Hawley, D. A., & Bradley, P. (2009). Hepatitis C: experiencing stigma. Gastroenterol Nurs, 32(2), 94-104. doi: 10.1097/SGA.0b013e31819de48b
    連結:
  91. Morasco, B., Lovejoy, T., Turk, D., Crain, A., Hauser, P., & Dobscha, S. (2013). Biopsychosocial factors associated with pain in veterans with the hepatitis C virus. Journal of behavioral medicine, 1-10. doi: 10.1007/s10865-013-9549-y
    連結:
  92. Murphy, D. A., Roberts, K. J., Hoffman, D., Molina, A., & Lu, M. C. (2003). Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients. Aids Care, 15(2), 217-230. doi: 10.1080/0954012031000068362
    連結:
  93. Na, L., & Na, B. (2013). A revolutionary road: An analysis of persons living with hepatitis B in China. Journal of Health Communication, 18(1), 71-91. doi: 10.1080/10810730.2012.688449
    連結:
  94. Nagano, J., Nagase, S., Sudo, N., & Kubo, C. (2004). Psychosocial stress, personality, and the severity of chronic hepatitis C. Psychosomatics, 45(2), 100-106.
    連結:
  95. Omata, M., Kanda, T., Yu, M. L., Yokosuka, O., Lim, S. G., Jafri, W., . . . McCaughan, G. W. (2012). APASL consensus statements and management algorithms for hepatitis C virus infection. Hepatol Int, 6(2), 409-435. doi: 10.1007/s12072-012-9342-y
    連結:
  96. Park, H., & Kim, M. T. (2012). Impact of social role strain, depression, social support and age on diabetes self-efficacy in Korean women with type 2 diabetes. J Cardiovasc Nurs, 27(1), 76-83. doi: 10.1097/JCN.0b013e318214d9d9
    連結:
  97. Pelle, A. J., Schiffer, A. A., Smith, O. R., Widdershoven, J. W., & Denollet, J. (2010). Inadequate consultation behavior modulates the relationship between Type D personality and impaired health status in chronic heart failure. International journal of cardiology, 142(1), 65-71.
    連結:
  98. Pessione, F., Ramond, M.-J., Njapoum, C., Duchatelle, V., Degott, C., Erlinger, S., . . . Degos, F. (2001). Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology, 34(1), 121-125.
    連結:
  99. Porter, L. S., Keefe, F. J., Garst, J., McBride, C. M., & Baucom, D. (2008). Self-efficacy for managing pain, symptoms, and function in patients with lung cancer and their informal caregivers: associations with symptoms and distress. Pain, 137(2), 306-315. doi: 10.1016/j.pain.2007.09.010
    連結:
  100. Quinn, D. M., & Earnshaw, V. A. (2011). Understanding Concealable Stigmatized Identities: The Role of Identity in Psychological, Physical, and Behavioral Outcomes. Social Issues and Policy Review, 5(1), 160-190. doi: 10.1111/j.1751-2409.2011.01029.x
    連結:
  101. Rosen, H. R. (2011). Chronic hepatitis C infection. New England Journal of Medicine, 364(25), 2429-2438.
    連結:
  102. Rusch, N., Corrigan, P. W., Wassel, A., Michaels, P., Olschewski, M., Wilkniss, S., & Batia, K. (2009). A stress-coping model of mental illness stigma: I. Predictors of cognitive stress appraisal. Schizophr Res, 110(1-3), 59-64. doi: 10.1016/j.schres.2009.01.006
    連結:
  103. Rusu, E., Jinga, M., Enache, G., Rusu, F., Dragomir, A. D., Ancuta, I., . . . Sima, I. (2013). Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C–a randomized trial. Nutrition journal, 12(1), 119.
    連結:
  104. Saffari, M., Alavian, S. M., Naderi, M. K., Pakpour, A. H., Al Zaben, F., & Koenig, H. G. (2015). Cross-Cultural Adaptation and Psychometric Assessment of the Liver Disease Symptom Index 2.0 to Measure Health-Related Quality of Life Among Iranian Patients With Chronic Hepatitis B. J Transcult Nurs. doi: 10.1177/1043659615577698
    連結:
  105. Saunders, J. C., & Cookman, C. A. (2005). A clarified conceptual meaning of hepatitis C-related depression. Gastroenterology Nursing, 28(2), 123-129.
    連結:
  106. Schiffer, A. A., Denollet, J., Widdershoven, J. W., Hendriks, E. H., & Smith, O. R. (2007). Failure to consult for symptoms of heart failure in patients with a type-D personality. Heart, 93(7), 814-818.
    連結:
  107. Sharoni, S. K., & Wu, S. F. (2012). Self-efficacy and self-care behavior of Malaysian patients with type 2 diabetes: a cross sectional survey. Nurs Health Sci, 14(1), 38-45. doi: 10.1111/j.1442-2018.2011.00658.x
    連結:
  108. Shin, Y., Jang, H., & Pender, N. J. (2001). Psychometric evaluation of the exercise self-efficacy scale among Korean adults with chronic diseases. Research in Nursing & Health, 24(1), 68-76. doi: 10.1002/1098-240X(200102)24:1<68::AID-NUR1008>3.0.CO;2-C
    連結:
  109. Shrestha, A. D., Kosalram, K., & Gopichandran, V. (2013). Gender difference in care of type 2 diabetes. Journal of the Nepal Medical Association, 52(5), 245-250.
    連結:
  110. Shun, S. C., Hsiao, F. H., Lai, Y. H., Liang, J. T., Yeh, K. H., & Huang, J. (2011). Personality trait and quality of life in colorectal cancer survivors. Oncol Nurs Forum, 38(3), E221-228. doi: 10.1188/11.onf.e221-e228
    連結:
  111. Silberbogen, A. K., Ulloa, E. W., Janke, E. A., & Mori, D. L. (2009). Psychosocial issues and mental health treatment recommendations for patients with hepatitis C. Psychosomatics, 50(2), 114-122. doi: 10.1176/appi.psy.50.2.114
    連結:
  112. Sockalingam, S., Abbey, S. E., Alosaimi, F., & Novak, M. (2010). A review of sleep disturbance in hepatitis C. Journal of clinical gastroenterology, 44(1), 38-45.
    連結:
  113. Sontag, S. (1989). AIDS and its metaphors: Penguin London.
    連結:
  114. Soykan, A., Boztaş, H., Idilman, R., Özel, E., Tüzün, A., Özden, A., & Kumbasar, H. (2005). Sexual dysfunctions in HCV patients and its correlations with psychological and biological variables. International journal of impotence research, 17(2), 175-179.
    連結:
  115. Spiegel, B. M. R., Younossi, Z. M., Hays, R. D., Revicki, D., Robbins, S., & Kanwal, F. (2005). Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment. Hepatology, 41(4), 790-800. doi: 10.1002/hep.20659
    連結:
  116. Strader, D. B., Bacon, B. R., Lindsay, K. L., La Brecque, D. R., Morgan, T., Wright, E. C., . . . Seeff, L. B. (2002). Use of complementary and alternative medicine in patients with liver disease. The American journal of gastroenterology, 97(9), 2391-2397.
    連結:
  117. Sublette, V. A., Douglas, M. W., McCaffery, K., George, J., & Perry, K. N. (2013). Psychological, lifestyle and social predictors of hepatitis C treatment response: a systematic review. Liver International, 33(6), 894-903.
    連結:
  118. Sutton, R., & Treloar, C. (2007). Chronic illness experiences, clinical markers and living with hepatitis C. Journal of Health Psychology, 12(2), 330-340.
    連結:
  119. Temple‐Smith, M., Stoove, M., Smith, A., O'Brien, M., Mitchell, D., Banwell, C., . . . Gifford, S. (2007). Gender differences in seeking care for hepatitis C in Australia. Journal of Substance Use, 12(1), 59-70.
    連結:
  120. Ünal, G., de Boer, J. B., Borsboom, G. J., Brouwer, J. T., Essink-Bot, M.-L., & de Man, R. A. (2001). A psychometric comparison of health-related quality of life measures in chronic liver disease. Journal of clinical epidemiology, 54(6), 587-596.
    連結:
  121. Van Der Plas, S. M., Hansen, B. E., De Boer, J. B., Stijnen, T., Passchier, J., Rob, A., & Schalm, S. W. (2004). The Liver Disease Symptom Index 2.0; validation of a disease-specific questionnaire. Quality of Life Research, 13(8), 1469-1481.
    連結:
  122. Vanable, P. A., Carey, M. P., Blair, D. C., & Littlewood, R. A. (2006). Impact of HIV-related stigma on health behaviors and psychological adjustment among HIV-positive men and women. AIDS and Behavior, 10(5), 473-482.
    連結:
  123. Wang, C. S., Wang, S. T., Chang, T. T., Yao, W. J., & Chou, P. (2002). Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression. Arch Intern Med, 162(7), 811-815.
    連結:
  124. Wang, J. Q., & Ying, A. T. (2004). diabetes self-efficacy andself-care behaviour of Chinese patients living in shanghai. J Clin Nurs, 26(13), 771-772.
    連結:
  125. Wang, W. L., Wang, C. J., & Tseng, H. F. (2009). Comparing knowledge, health beliefs, and self-efficacy toward hepatitis B prevention among university students with different hepatitis B virus infectious statuses. J Nurs Res, 17(1), 10-19. doi: 10.1097/JNR.0b013e3181999ca3
    連結:
  126. Weiss, M. G., Ramakrishna, J., & Somma, D. (2006). Health-related stigma: Rethinking concepts and interventions 1. Psychol Health Med, 11(3), 277-287.
    連結:
  127. Weng, C.Y., Long, Q. H., Pedersen, S. S., Lin, C. L., Lin, T. K. (2009). Cross-validation of the Type D Scale (DS14) in Taiwanese cardiac patients and healthy controls. Psychosom Med, 71(3), 39.
    連結:
  128. Whiteley, D., Elliott, L., Cunningham-Burley, S., & Whittaker, A. (2015). Health-Related Quality of Life for individuals with hepatitis C: A narrative review. International Journal of Drug Policy, 26(10), 936-949. doi: 10.1016/j.drugpo.2015.04.019
    連結:
  129. Williams, L., O'Connor, R. C., Grubb, N. R., & O'Carroll, R. E. (2011). Type D personality and illness perceptions in myocardial infarction patients. J Psychosom Res, 70(2), 141-144. doi: 10.1016/j.jpsychores.2010.07.015
    連結:
  130. Williams, L., O'Connor, R. C., Howard, S., Hughes, B. M., Johnston, D. W., Hay, J. L., . . . Sheehy, N. (2008). Type-D personality mechanisms of effect: the role of health-related behavior and social support. J Psychosom Res, 64(1), 63-69.
    連結:
  131. Williams, L., O'Connor, R. C., Howard, S., Hughes, B. M., Johnston, D. W., Hay, J. L., . . . O'Carroll, R. E. (2008). Type-D personality mechanisms of effect: the role of health-related behavior and social support. J Psychosom Res, 64(1), 63-69. doi: 10.1016/j.jpsychores.2007.06.008
    連結:
  132. Williams, L., & Wingate, A. (2012). Type D personality, physical symptoms and subjective stress: the mediating effects of coping and social support. Psychol Health, 27(9), 1075-1085. doi: 10.1080/08870446.2012.667098
    連結:
  133. Wright, T. L., & Pereira, B. (1995). Liver transplantation for chronic viral hepatitis. Liver Transplantation and Surgery, 1(1), 30-42.
    連結:
  134. Wu, H., Yim, C., Chan, A., Ho, M., & Heathcote, J. (2009). Sociocultural factors that potentially affect the institution of prevention and treatment strategies for prevention of hepatitis B in Chinese Canadians. Can J Gastroenterol, 23(1), 31-36.
    連結:
  135. Wu, J.-R., Song, E. K., & Moser, D. K. (2015). Type D personality, self-efficacy, and medication adherence in patients with heart failure—A mediation analysis. Heart & Lung: The Journal of Acute and Critical Care, 44(4), 276-281. doi: http://dx.doi.org/10.1016/j.hrtlng.2015.03.006
    連結:
  136. Wu, S. F., Huang, Y. C., Lee, M. C., Wang, T. J., Tung, H. H., & Wu, M. P. (2013). Self-efficacy, self-care behavior, anxiety, and depression in Taiwanese with type 2 diabetes: A cross-sectional survey. Nurs Health Sci. doi: 10.1111/nhs.12022
    連結:
  137. Youssef, N. F., Shepherd, A., Evans, J. M., & Wyke, S. (2012). Translating and testing the Liver Disease Symptom Index 2.0 for administration to people with liver cirrhosis in Egypt. International journal of nursing practice, 18(4), 406-416.
    連結:
  138. Zandi, M., Adib-Hajbagheri, M., Memarian, R., Nejhad, A. K., & Alavian, S. M. (2005). Effects of a self-care program on quality of life of cirrhotic patients referring to Tehran Hepatitis Center. Health Qual Life Outcomes, 3, 35. doi: 10.1186/1477-7525-3-35
    連結:
  139. Zhang, M.-f., Zheng, M.-c., Liu, W.-y., Wen, Y.-s., Wu, X.-d., & Liu, Q.-w. (2015). The influence of demographics, psychological factors and self-efficacy on symptom distress in colorectal cancer patients undergoing post-surgical adjuvant chemotherapy. European Journal of Oncology Nursing, 19(1), 89-96.
    連結:
  140. Zickmund, S., Ho, E. Y., Masuda, M., Ippolito, L., & LaBrecque, D. R. (2003). "They treated me like a leper". Stigmatization and the quality of life of patients with hepatitis C. J Gen Intern Med, 18(10), 835-844.
    連結:
  141. 王秀紅(2000)。自我照顧的概念及其在國內護理研究應用之評析。護理雜誌,47(2),64-70。
    連結:
  142. 王婉璇、黃子庭、靳燕芬、魏真真(2010)。某大學 B 型肝炎帶原學生自我照顧行為之探討-Orem 自我照顧缺失理論之應用。護理暨健康照護研究, 6(3),172-182。
    連結:
  143. 王鼐(2015)。站在巨人的肩膀上看世界 C 型肝炎真的可以治癒嗎? 愛之關懷季刊,(92),23-31。
    連結:
  144. 江素嬌(2010)。B型肝炎帶原者接受追蹤檢查行為影響因素探討-以某基金會肝炎篩檢活動帶原者為例(未出版之碩士論文)。國立臺灣師範大學,台北市。
    連結:
  145. 朱嘉明(2003)。急性病毒性肝炎。當代醫學,(351),4-12。
    連結:
  146. 行政院衛生署全民健康保險爭議審議委員會(2006)。慢性肝症腹部超音波檢查頻數之爭議。臺灣醫學, 10(2),234-236。
    連結:
  147. 呂慧貞(2006)。影響C型肝炎病患就醫因素之探討─以台北市某醫學中心為例(未出版之碩士論文)。台北醫學大學,台北市。
    連結:
  148. 宋瑞樓(2000)。肝癌之認知。陶聲洋防癌之聲,91,2-5。
    連結:
  149. 李尹暘、林曉佩、林君怡(2007)。自我效能理論之分析與應用。澄清醫護管理雜誌, 3(2),46-52。
    連結:
  150. 李官燁、盛望徽(2013)。愛滋病毒感染者之 B 型肝炎流行病學與治療相關問題。愛之關懷季刊,83,16-27。
    連結:
  151. 侯明志、吳肇卿(1994)。異性性接觸是臺灣成人急性 B 型肝炎最重要的傳染途徑-成人接種 B 型肝炎疫苗的必要性。疫情報導,10(7),173-179。
    連結:
  152. 高偉育、陳明堯、張君照(2013)。淺談慢性B型和C型肝炎最新治療指引。台北市醫師公會會刊,57(9),15-21。
    連結:
  153. 高嘉宏(2012a)。B 型肝炎最新治療指引。健康世界,(319),16-21。
    連結:
  154. 高嘉宏(2012b)。C型肝炎患者罹患肝癌的風險預測。健康世界,(321),47-50。
    連結:
  155. 高嘉宏(2012c)。慢性C型肝炎治療準則。取自
    連結:
  156. 高嘉宏 (2012d)。C型肝炎患者罹患肝癌的風險預測。健康世界,(321),47-50。
    連結:
  157. 張育霖(2012)。概述慢性 C 型肝炎與脂肪肝及胰島素抗性之關連。內科學誌, 23(4),267-273。
    連結:
  158. 張家華(2012)。C型肝炎抗體 (anti-HCV) 於台灣高度流行區引發陽性盛行率之變化探討(未出版之碩士論文)。高雄醫學大學,高雄市。
    連結:
  159. 許景盛、高嘉宏(2010)。病毒性肝炎與代謝症候群。當代醫學,441,485-497。
    連結:
  160. 陳宏梅 (2006)。慢性 C 型肝炎患者接受干擾素合併 Ribavirin 治療遵從行為及其相關因素探討(未出版之碩士論文)。國立台灣大學,台北市。
    連結:
  161. 陳志軒、徐畢卿、李靜姝、黃建豪(2012)。健康研究中的烙印議題。臺灣醫學, 16(1),84-92。
    連結:
  162. 陳定信 (2009)。總計劃:肝炎防治政策評估。行政院衛生署疾病管制局九十六-九十八年度委託研究計劃 (編號:DOH96-DC-1018)。台北市:行政院衛生署疾病管制局。
    連結:
  163. 陳義隆、盧勝男、吳正禮(1999)。B 型及 C 型肝炎盛行鄉內各村之間的盛行率差異: 高雄縣梓官鄉之社區研究。中華公共衛生雜誌,18(5),313-318。
    連結:
  164. 黃憲鐘、王正松、許家得(2006)。運動與病毒性肝炎相關研究之探討。彰化師大體育學報,6,85-93。
    連結:
  165. 楊培銘(1998)。慢性B型肝炎之治療。臺灣醫學,2(6),654-660。
    連結:
  166. 廖運範(2009)。挑戰B 型肝炎∼台灣經典(二)B型肝炎的傳染。當代醫學,434,936-941。
    連結:
  167. 劉俊人、許景盛、高嘉宏(2012)。慢性 C 型肝炎治療的新進展: 從干擾素到直接抗病毒藥物。內科學誌, 23(6),383-391。
    連結:
  168. 厲佩如(2012)。C型肝炎民眾之相關知識、症狀困擾及因應行為之相關性研究(未出版之碩士論文)。高雄醫學大學,高雄市。
    連結:
  169. 蔣立琦、郭雅雯、林綽娟(2004)。自我效能之概念分析。護理雜誌,51(2),67-72。doi: 10.6224/jn.51.2.67
    連結:
  170. 鄭仰志、方聖惟、張甄、謝清睿、羅鴻源、劉正典、張君照(2011)。急性 B 型肝炎的治療探討。內科學誌,22, 99-105。
    連結:
  171. 鄭健禹(2012)。愛滋病毒感染者的 C 型肝炎治療與新陳代謝異常。愛之關懷季刊,78,46-51。
    連結:
  172. 蕭宗賢、李宜謙、蘇東弘、高嘉宏(2008)。B型肝炎治療之新進展。當代醫學,417,517-530。
    連結:
  173. 簡榮南(2012)。慢性 B 型肝炎治療的現況。內科學誌,23(6),377-382。
    連結:
  174. 羅錦河(2004)。慢性B型肝炎急性發作?。健康世界,(228),92-97。
    連結:
  175. 譚健民(2009)。慢性B型肝炎治療的今日觀由2009年EASL肝病世界年會談起。臺灣醫界,52(10),26-32。
    連結:
  176. 英文部份
  177. Ablon, J. (1981). Stigmatized health conditions. Social Science & Medicine. Part B: Medical Anthropology, 15(1), 5-9.
  178. Bandura, A. (1986). Social foundations of thought and action: Englewood Cliffs, NJ Prentice Hall.
  179. Daniel, M., Cargo, M. D., Lifshay, J., & Green, L. W. (2004). Cigarette smoking, mental health and social support: data from a northwestern First Nation. Canadian Journal of Public Health/Revue Canadienne de Sante'e Publique, 45-49.
  180. Fullilove, M. T. (1989). Anxiety and stigmatizing aspects of HIV infection. Journal of Clinical Psychiatry.
  181. Link, B. G., & Phelan, J. C. (2001). Conceptualizing stigma. Annual review of Sociology, 363-385.
  182. Lubkin, I. M., & Larsen, P. D. (2013). Chronic illness : impact and intervention. Burlington, Mass.: Jones & Bartlett Learning.
  183. Modabbernia, A., Ashra, M., Malekzadeh, R., & Poustchi, H. (2013). A review of psychosocial issues in patients with chronic hepatitis B. Archives of Iranian Medicine, 16(2), 114-122.
  184. Moore, G. A., Hawley, D. A., & Bradley, P. (2008). Hepatitis C: studying stigma. Gastroenterol Nurs, 31(5), 346-352. doi: 10.1097/01.sga.0000338279.40412.96
  185. Orem, D. E., Taylor, S. G., & Renpenning, K. M. (1991). Nursing: Concepts of practice.
  186. Poynard, T., Cacoub, P., Ratziu, V., Myers, R., Dezailles, M., Mercadier, A., . . . Moussalli, J. (2002). Fatigue in patients with chronic hepatitis C. Journal of Viral Hepatitis, 9(4), 295-303.
  187. Riley, T. R., 3rd, & Koch, K. (2003). Characteristics of upper abdominal pain in those with chronic liver disease. Dig Dis Sci, 48(10), 1914-1918.
  188. Smith, G., Ferguson, P. L., Saunders, L. L., Wagner, J. L., Wannamaker, B. B., & Selassie, A. W. (2009). Psychosocial factors associated with stigma in adults with epilepsy. Epilepsy & Behavior, 16(3), 484-490. doi: http://dx.doi.org/10.1016/j.yebeh.2009.08.028
  189. Spicker, P. (1984). Stigma and social welfare: New York : St. Martin's Press.
  190. Yang, L. H., Kleinman, A., Link, B. G., Phelan, J. C., Lee, S., & Good, B. (2007). Culture and stigma: adding moral experience to stigma theory. Social Science & Medicine, 64(7), 1524-1535.
  191. 中文部份
  192. 江敏(2014)。保健食品傷肝?!有影抹?。好心肝:肝病防治會刊,66,18-20。
  193. 行政院衛生福利部 (2015年7月) 。民國103年度死因統計年報。取自
  194. http://www.mohw.gov.tw/cht/DOS/Statistic.aspx?f_list_no=312&fod_list_no=5488
  195. 余秀珊、白明忠 (2015)。慢性 C 型肝炎病毒在台灣東部地區感染與治療之現況。生物醫學暨檢驗雜誌,27(3),95-102。
  196. 李萬山(2011)。肝病生活宜忌:愛肝健康32種保健方法你必須知道的保肝知識。新北市:漢宇國際文化。
  197. 林宗鴻譯,Burger, J. M. 原著(2003)。人格心理學。台北:揚智文化。
  198. 洪小幸(2007)。台灣肝病臨床指引依從性及其相關影響因素探討(未出版之碩士論文)。國立陽明大學,台北市。
  199. 洪娟娟(1998)。受刑人配偶關連烙印現象之初探(未出版之碩士論文)。東吳大學,台北市。
  200. 洪春霞, 魏欽令、程敏鋒、王相藍、韓自力 (2011)。慢性肝炎患者病恥感及其對交往焦慮、一般自我效能感的影響。中華行為醫學與腦科學雜誌,20 ( 9 ),809-811。
  201. 唐蘊慧(2012)。探討中部某區域醫院慢性C型肝炎病患接受干擾素合併雷巴威林治療期間之自我效能、社會支持、身體症狀、情緒狀態與遵從行為之比較研究(未出版之碩士論文)。弘光科技大學,台中市。
  202. http://www.tsim.org.tw/article/A96/B1-22.pdf
  203. 許金川(2010)。遠離肝苦很簡單:你必須知道的保肝知識。臺北市:如何。
  204. 陳慧如(2012)。全民健康保險B型肝炎帶原者及C型肝炎感染者醫療給付改善方案之先導研究(未出版之碩士論文)。國立陽明大學,台北市。
  205. 陳健弘(2010)。找回健康肝:肝炎.肝硬化.肝癌防治知識全覽。臺北市:原水文化。
  206. 馮麗芬、謝俊強、鄒霞、黃靜芝、郭為林、顧菁(2012)。慢性乙肝病毒感染者歧視測量量表信效度的初步研究。中華行為醫學與腦科學雜誌,21(4),370-372。
  207. 楊培銘(2002)。GOT、GPT、AFP正常又沒有症狀怎麼會長肝癌?。好心肝:肝病防治會刊,18, 34-36。
  208. 楊培銘(2002b)。保肝片能不能保肝?。好心肝:肝病防治會刊,19,22-23。
  209. 劉小瑜(2011)。台灣慢性病毒性肝炎患者之慢性病發生率及全死因之風險探討(未出版之碩士論文)。國防醫學院,台北市。
  210. 魯惠雲(2014)。本會C肝患者電話關懷追蹤大調查。好心肝:肝病防治會刊,65,18-21
  211. 鍾玉琪(2011)。台灣版D型人格量表-DS14再次修訂(未出版之碩士論文)。國立中正大學,嘉義縣。